SGH
ARIA

Schonfeld Group Holdings’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Schonfeld Group Holdings’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-42,703
Closed -$344K – 450
2014
Q1 		$344K Buy
+42,703
New +$333K 0.09% 343
2013
Q4 		– Sell
-11,800
Closed -$217K – 417
2013
Q3 		$217K Buy
+11,800
New +$229K 0.44% 91

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Schonfeld Group Holdings's ARIA Position: Q2 2014 in Review

Schonfeld Group Holdings sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 42,703 shares — an estimated $344K sold.

Schonfeld Group Holdings first reported a position in ARIA in Q3 2013 and held it in 2 quarters. The position peaked at $344K in Q1 2014. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

  • Schonfeld Group Holdings reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Schonfeld Group Holdings sold 42,703 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $344K.
  • Schonfeld Group Holdings first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 2 quarters.
  • Schonfeld Group Holdings's Ariad Pharmaceuticals Inc position peaked at $344K in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Schonfeld Group Holdings's 13F filing for Q2 2014, filed 15 Aug 2014.